Common Stock, Shares, Issued of THC Therapeutics, Inc. from 15 Mar 2010 to 31 Jul 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
THC Therapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 15 Mar 2010 to 31 Jul 2024.
  • THC Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Jul 2024 was 40,266,149, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

THC Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 40,266,149 +6,120,000 +18% 31 Jul 2024 10-K 27 Feb 2026 2024 FY
Q1 2024 40,266,149 +6,120,000 +18% 30 Apr 2024 10-Q 13 Nov 2024 2024 Q3
Q4 2023 32,746,149 -1,400,000 -4.1% 31 Jan 2024 10-Q 05 Sep 2024 2024 Q2
Q3 2023 32,746,149 -1,400,000 -4.1% 31 Oct 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2023 34,146,149 +254,478 +0.75% 31 Jul 2023 10-K 27 Feb 2026 2024 FY
Q1 2023 34,146,149 +1,654,478 +5.1% 30 Apr 2023 10-Q 09 Jan 2024 2023 Q3
Q4 2022 34,146,149 +1,654,478 +5.1% 31 Jan 2023 10-Q 08 Jan 2024 2023 Q2
Q3 2022 34,146,149 +708,978 +2.1% 31 Oct 2022 10-Q 22 Dec 2022 2023 Q1
Q2 2022 33,891,671 +4,604,334 +16% 31 Jul 2022 10-K 26 Feb 2024 2023 FY
Q1 2022 32,491,671 +8,313,811 +34% 30 Apr 2022 10-Q 16 Jun 2022 2022 Q3
Q4 2021 32,491,671 +8,313,811 +34% 31 Jan 2022 10-Q 16 May 2022 2022 Q2
Q3 2021 33,437,171 +11,256,479 +51% 31 Oct 2021 10-Q 16 May 2022 2022 Q1
Q2 2021 29,287,337 +7,825,589 +36% 31 Jul 2021 10-K 25 Nov 2022 2022 FY
Q1 2021 24,177,860 +5,204,194 +27% 30 Apr 2021 10-Q 22 Jun 2021 2021 Q3
Q4 2020 24,177,860 +9,155,081 +61% 31 Jan 2021 10-Q 29 Mar 2021 2021 Q2
Q3 2020 22,180,692 +21,923,031 +8508% 31 Oct 2020 10-Q 17 Dec 2020 2021 Q1
Q2 2020 21,461,748 +7,027,650 +49% 31 Jul 2020 10-K 31 Mar 2022 2021 FY
Q1 2020 18,973,666 +5,202,634 +38% 30 Apr 2020 10-Q 22 Jun 2020 2020 Q3
Q4 2019 15,022,779 +1,915,589 +15% 31 Jan 2020 10-Q 23 Mar 2020 2020 Q2
Q3 2019 257,661 -12,745,928 -98% 01 Oct 2019 10-Q 17 Dec 2020 2021 Q1
Q2 2019 14,434,098 +1,429,358 +11% 31 Jul 2019 10-K 04 Nov 2020 2020 FY
Q1 2019 13,771,032 30 Apr 2019 10-Q 14 Jun 2019 2019 Q3
Q4 2018 13,107,190 31 Jan 2019 10-Q 15 Mar 2019 2019 Q2
Q3 2018 13,003,589 31 Oct 2018 10-Q 19 Dec 2018 2019 Q1
Q2 2018 13,004,740 31 Jul 2018 10-K/A 18 Nov 2019 2020 FY
Q1 2014 76,037,262 +13,000,000 +21% 30 Apr 2014 10-Q 12 Jun 2014 2013 Q3
Q4 2013 76,037,262 +13,000,000 +21% 31 Jan 2014 10-Q 12 Jun 2014 2013 Q2
Q3 2013 76,037,262 +13,000,000 +21% 31 Oct 2013 10-Q 11 Jun 2014 2013 Q1
Q2 2013 74,037,262 +11,000,000 +17% 31 Jul 2013 10-Q 12 Jun 2014 2013 Q3
Q1 2013 63,037,262 +62,370,595 +9356% 30 Apr 2013 10-Q 11 Jun 2013 2013 Q3
Q4 2012 63,037,262 +8,313,143 +15% 31 Jan 2013 10-Q 21 Mar 2013 2013 Q2
Q3 2012 63,037,262 +8,313,143 +15% 31 Oct 2012 10-Q 14 Dec 2012 2013 Q1
Q2 2012 63,037,262 +8,313,143 +15% 31 Jul 2012 10-K 09 Jun 2014 2013 FY
Q1 2012 666,667 27 Mar 2012 10-Q 12 Jun 2014 2013 Q3
Q4 2011 54,724,119 31 Jan 2012 10-Q 21 Mar 2012 2012 Q2
Q3 2011 54,724,119 31 Oct 2011 10-Q 20 Dec 2011 2012 Q1
Q2 2011 54,724,119 31 Jul 2011 10-K 13 Nov 2012 2012 FY
Q1 2010 191,176,470 15 Mar 2010 10-Q 12 Jun 2014 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.